Telesair receives CE mark for oxygen system
By HME News Staff
Updated 10:13 AM CDT, Wed August 23, 2023
IRVINE, Calif. – Telesair has received CE (Conformité Européenne) Marks for its Bonhawa High Flow Oxygen Therapy (HFOT) system for use in the treatment of patients with respiratory insufficiency. The light and compact device features an extended flow range up to 80 L/pm, a simple disinfection process and an easy-to-use touchscreen, allowing greater therapeutic range, efficient disinfection, the potential to reduce the workload of caregivers, and the ability to visualize patient settings and data from outside the room. “Having our Bonhawa system approved for Europe is a major step in the evolution of Telesair as a company and opens the many markets which accept CE Mark,” said Bryan Liu, CEO. “We were able to accomplish this goal in record time – less than 10 months – thanks to our combination of a great team of experienced professionals, genuinely innovative respiratory technology products, attention to detail, high-level process control, and exceptional value.” Telesair's CE Mark and introduction of its lightweight oxygen therapy system to Europe further expands the company's existing market access that includes Latin America and Southeast Asia.
Comments